Ahuva Hanau

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

Derek Weycker, Mark Hatfield, Aaron Grossman et al. · BMC Cancer · 2019 · 121 citations · Full text

Medicine, Hematology, Oncology +17

Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis

Derek Weycker, Ahuva Hanau, Mark Hatfield et al. · Journal of Medical Economics · 2019 · 61 citations · Full text

Public Health, Hematology, Clinical Epidemiology +15

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

Derek Weycker, Xiaoyan Li, Gail Wygant et al. · Thrombosis and Haemostasis · 2018 · 45 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

Derek Weycker, Robin Doroff, Ahuva Hanau et al. · BMC Cancer · 2019 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15

Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims

Derek Weycker, Ahuva Hanau, Alexander Lonshteyn et al. · Current Medical Research and Opinion · 2018 · 15 citations

Medicine, Geriatric Medicine, Oncology +14